Unknown

Dataset Information

0

The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date.


ABSTRACT: Osteoarthritis (OA) is a complex heterogeneous articular disease with multiple joint tissue involvement of varying severity and no regulatory-agency-approved disease-modifying drugs (DMOADs). In this review, we discuss the reasons necessitating the development of DMOADs for OA management, the classifications of clinical phenotypes or molecular/mechanistic endotypes from the viewpoint of targeted drug discovery, and then summarize the efficacy and safety profile of a range of targeted drugs in Phase 2 and 3 clinical trials directed to cartilage-driven, bone-driven, and inflammation-driven endotypes. Finally, we briefly put forward the reasons for failures in OA clinical trials and possible steps to overcome these barriers.

SUBMITTER: Oo WM 

PROVIDER: S-EPMC8273751 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8098772 | biostudies-literature
| S-EPMC6816258 | biostudies-literature
| S-EPMC6717563 | biostudies-literature
| S-EPMC3899477 | biostudies-literature
| S-EPMC10727073 | biostudies-literature
| S-EPMC7238896 | biostudies-literature
| S-EPMC8885119 | biostudies-literature
| S-EPMC7823546 | biostudies-literature
| S-EPMC8013440 | biostudies-literature
| S-EPMC7845464 | biostudies-literature